FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024575679> ?p ?o ?g. }

• W2024575679 endingPage "64" @default.
• W2024575679 startingPage "56" @default.
• W2024575679 abstract "Experimental antiphospholipid syndrome (eAPS) induced by immunization with β2-glycoprotein I (β2-GPI) causes behavioral hyperactivity. We assessed the role of thrombotic and inflammatory perivascular factors and standard APS therapies for CNS manifestations. Groups of mice (n = 10 per group) were immunized once with β2-GPI (eAPS) or adjuvant (controls) and treated daily from 1 month after immunization with either sham injections, aspirin (1.2 mg/kg) or enoxaparin (1 mg/kg) for 3 months. Serum antiphospholipid antibodies (aPL) and brain levels of tissue necrosis factor-α (TNF-α) and prostaglandin E (PGE) were then measured by ELISA and thrombin inhibitors by immunoblot. Behavioral hyperactivity was assessed by the staircase test. The eAPS mice had higher levels of aPL than adjuvant immunized controls. Inflammatory markers were found to be twofold higher and intrinsic brain thrombin inhibitors 50% lower in eAPS brains compared to controls. aPL titers were unaffected by treatment. Both aspirin and enoxaparin normalized brain concentrations of PGE and TNF-α and elevated thrombin inhibitors, the latter effect being more pronounced for enoxaparin. The increased activity and rearing exploratory behavior in eAPS (138.6 ± 13.6 and 141.9 ± 13.9% of controls, respectively) were attenuated significantly more by treatment with enoxaparin (91.5 ± 12.3 and 95.0 ± 9.8%) than by aspirin (167.0 ± 18.4 and 114.7 ± 13.1%, p < 0.01, ANOVA). Together, these results demonstrate that eAPS is associated with significant brain inflammation and thrombosis that are well treated with both standard therapies for human APS. Enoxaparin attenuates behavior better than aspirin possibly by reducing thrombosis or stabilization of the blood brain barrier, suggesting an advantage for similar drugs in CNS APS." @default.
• W2024575679 created "2016-06-24" @default.
• W2024575679 creator A5004771713 @default.
• W2024575679 creator A5013311937 @default.
• W2024575679 creator A5014403258 @default.
• W2024575679 creator A5018838382 @default.
• W2024575679 creator A5024658913 @default.
• W2024575679 creator A5031694589 @default.
• W2024575679 creator A5035718002 @default.
• W2024575679 creator A5072166912 @default.
• W2024575679 creator A5074738902 @default.
• W2024575679 date "2008-04-01" @default.
• W2024575679 modified "2023-10-01" @default.
• W2024575679 title "Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome" @default.
• W2024575679 cites W1600697457 @default.
• W2024575679 cites W1960588499 @default.
• W2024575679 cites W1970318104 @default.
• W2024575679 cites W1972368562 @default.
• W2024575679 cites W1978292506 @default.
• W2024575679 cites W1978741231 @default.
• W2024575679 cites W1982562954 @default.
• W2024575679 cites W1982762119 @default.
• W2024575679 cites W1992722639 @default.
• W2024575679 cites W1997693267 @default.
• W2024575679 cites W2007876469 @default.
• W2024575679 cites W2018948925 @default.
• W2024575679 cites W2023052741 @default.
• W2024575679 cites W2026792719 @default.
• W2024575679 cites W2027168053 @default.
• W2024575679 cites W2031551539 @default.
• W2024575679 cites W2032120350 @default.
• W2024575679 cites W2044052345 @default.
• W2024575679 cites W2049278423 @default.
• W2024575679 cites W2053081517 @default.
• W2024575679 cites W2054495051 @default.
• W2024575679 cites W2054674683 @default.
• W2024575679 cites W2060443531 @default.
• W2024575679 cites W2068469174 @default.
• W2024575679 cites W2070162478 @default.
• W2024575679 cites W2070863059 @default.
• W2024575679 cites W2077088913 @default.
• W2024575679 cites W2092584114 @default.
• W2024575679 cites W2099005866 @default.
• W2024575679 cites W2105536474 @default.
• W2024575679 cites W2109656144 @default.
• W2024575679 cites W2110502968 @default.
• W2024575679 cites W2113891001 @default.
• W2024575679 cites W2127278284 @default.
• W2024575679 cites W2131087113 @default.
• W2024575679 cites W2155433659 @default.
• W2024575679 cites W2276292771 @default.
• W2024575679 cites W2324589358 @default.
• W2024575679 doi "https://doi.org/10.1016/j.nbd.2007.12.004" @default.
• W2024575679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18308578" @default.
• W2024575679 hasPublicationYear "2008" @default.
• W2024575679 type Work @default.
• W2024575679 sameAs 2024575679 @default.
• W2024575679 citedByCount "43" @default.
• W2024575679 countsByYear W20245756792012 @default.
• W2024575679 countsByYear W20245756792013 @default.
• W2024575679 countsByYear W20245756792014 @default.
• W2024575679 countsByYear W20245756792015 @default.
• W2024575679 countsByYear W20245756792016 @default.
• W2024575679 countsByYear W20245756792017 @default.
• W2024575679 countsByYear W20245756792018 @default.
• W2024575679 countsByYear W20245756792019 @default.
• W2024575679 countsByYear W20245756792020 @default.
• W2024575679 countsByYear W20245756792021 @default.
• W2024575679 countsByYear W20245756792022 @default.
• W2024575679 crossrefType "journal-article" @default.
• W2024575679 hasAuthorship W2024575679A5004771713 @default.
• W2024575679 hasAuthorship W2024575679A5013311937 @default.
• W2024575679 hasAuthorship W2024575679A5014403258 @default.
• W2024575679 hasAuthorship W2024575679A5018838382 @default.
• W2024575679 hasAuthorship W2024575679A5024658913 @default.
• W2024575679 hasAuthorship W2024575679A5031694589 @default.
• W2024575679 hasAuthorship W2024575679A5035718002 @default.
• W2024575679 hasAuthorship W2024575679A5072166912 @default.
• W2024575679 hasAuthorship W2024575679A5074738902 @default.
• W2024575679 hasConcept C126322002 @default.
• W2024575679 hasConcept C203014093 @default.
• W2024575679 hasConcept C2776874634 @default.
• W2024575679 hasConcept C2777628954 @default.
• W2024575679 hasConcept C2777863537 @default.
• W2024575679 hasConcept C2780868729 @default.
• W2024575679 hasConcept C42219234 @default.
• W2024575679 hasConcept C71924100 @default.
• W2024575679 hasConcept C98274493 @default.
• W2024575679 hasConceptScore W2024575679C126322002 @default.
• W2024575679 hasConceptScore W2024575679C203014093 @default.
• W2024575679 hasConceptScore W2024575679C2776874634 @default.
• W2024575679 hasConceptScore W2024575679C2777628954 @default.
• W2024575679 hasConceptScore W2024575679C2777863537 @default.
• W2024575679 hasConceptScore W2024575679C2780868729 @default.
• W2024575679 hasConceptScore W2024575679C42219234 @default.
• W2024575679 hasConceptScore W2024575679C71924100 @default.
• W2024575679 hasConceptScore W2024575679C98274493 @default.
• W2024575679 hasIssue "1" @default.

• next